Latest GMOs Publications
Board minute extract for Agency Board Meeting of 9 April 2013
Year: 2013
An extract from the minutes of the EPA Board Meeting of 9 April 2013, at which Intervet International BV's notification seeking consent to carry out a veterinary trial at Belmont Stud, Co Offaly, was discussed.
GM equine vaccine Equilis RhodE application
Year: 2013
Non-confidential application documentation for Merck Sharp and Dohme application on behalf of Intervet International BV for consent to carry out a clinical study with a GM vaccine
Requests for further information, and responses received
Year: 2013
Requests from the Agency to the notifier for additional information, and the responses received, including an amended SNIF.
GMO Register G0498-01
Year: 2013
The GMO Register entry provides significant details of the clinical trial
Environmental Risk Assessment Dossier
Year: 2013
Environmental Risk Assessment Dossier for Clinical Trial G0498-01
Requests for further information and replies
Year: 2013
Requests from the Agency to the notifier for additional information, and the responses received.
Technical Dossier Non-Confidential
Year: 2013
Environmental Risk Assessment Dossier (in accordance with Schedule II, SI 500 of 2003) for proposed Clinical Trial G0498-01
Part D Conclusions G0498-01
Year: 2013
Conclusions on the potential environmental impact from the release or the placing on the market of genetically modified organisms, re G0498-01
G0498-01 Inspector's Report
Year: 2013
All documentation submitted in respect of this notification was taken into consideration by the EPA Inspector in her report to the Board of the Agency
Board Minute Extract of 25 June 2013
Year: 2013
An extract from the minutes of the EPA Board Meeting of 25 June 2013 at which the Centre for Cellular and Molecular Therapeutics' notification seeking consent to carry out a clinical trial at St James's Hospital Dublin was discussed
G0498-01 Consent Conditions
Year: 2013
G0498-01 Consent Condition issued to The Centre for Cellular and Molecular Therapeutics at the Children's Hospital of Philadelphia, USA, on 3 July 2013 for a clinical trial using a Genetically Modified Organism (GMO) at St. James's Hospital Dublin
Summary Notification Information Format G0498-01
Year: 2013
Summary Notification Information Format for proposed Clinical Trial G0498-01
Response from Teagasc 14 June 2012
Year: 2013
Correspondence from Teagasc regarding 4 April 2012 and 23 May 2012 requests for further information
Response from Teagasc 11 April Part 2
Year: 2013
Teagasc's response, dated 11 April 2012, to EPA's request for further information, Part 2
Response from Teagasc 11 April Part 1
Year: 2013
Teagasc's response, dated 11 April 2012, to EPA's request for further information, Part 1
EPA letter to Teagasc issued April 2012
Year: 2013
EPA letter to Teagasc, issued 4 April 2012, requesting further information
How to make a representation
Year: 2013
The following information note sets out how persons may make a representation to the EPA in response to a newspaper notice under Part II of the GMO (Deliberate Release) Regulations, S.I. No. 500 of 2003.
EPA Letter to Teagasc issued March 2012
Letter to Teagasc from EPA requesting further information, January 2013
Year: 2013
Letter to Teagasc in March 2012 re GM Potato Field Trial
Newspaper Notice for field trial GM potatoes
Year: 2013
The following is the text of the newspaper notice published by Teagasc in the Irish Independent newspaper on 29 February 2012 in accordance with the requirements of Article 15 of the GMO (Deliberate Release) Regulations, S.I. No 500 of 2003